
SAMSARA BIOCAPITAL, LLC
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | KLRS | 12.95M | $109.28M |
![]() | RANI | 8.50M | $11.47M |
![]() | GOSS | 7.22M | $22.39M |
![]() | SRRK | 6.90M | $303.84M |
![]() | MLYS | 5.87M | $213.06M |
![]() | ALMS | 5.76M | $56.19M |
![]() | IVA | 5.19M | $24.16M |
![]() | NKTX | 3.51M | $6.49M |
![]() | SEPN | 3.15M | $87.80M |
![]() | AQST | 2.50M | $16.15M |
![]() | XFOR | 1.96M | $7.84M |
![]() | NGNE | 1.72M | $35.37M |
![]() | JBIO | 969K | $14.95M |
![]() | UPB | 736K | $19.98M |
![]() | VTVT | 298K | $11.94M |
![]() | STRO | 205K | $2.37M |
![]() | NUVB-WT | 124K | $40.96K |
![]() | PVLA | 105K | $10.97M |
![]() | ABVX | 75K | $10.17M |
![]() | CTNM | 72K | $825.76K |

Kalaris Therapeutics Inc
KLRS
Shares Held
12.95M
Value
$109.28M

Rani Therapeutics Holdings, Inc.
RANI
Shares Held
8.50M
Value
$11.47M

Gossamer Bio, Inc.
GOSS
Shares Held
7.22M
Value
$22.39M

Scholar Rock Holding Corporation
SRRK
Shares Held
6.90M
Value
$303.84M

Mineralys Therapeutics, Inc.
MLYS
Shares Held
5.87M
Value
$213.06M

Alumis Inc. Common Stock
ALMS
Shares Held
5.76M
Value
$56.19M

Inventiva S.A.
IVA
Shares Held
5.19M
Value
$24.16M

Nkarta, Inc.
NKTX
Shares Held
3.51M
Value
$6.49M

Septerna, Inc.
SEPN
Shares Held
3.15M
Value
$87.80M

Aquestive Therapeutics, Inc.
AQST
Shares Held
2.50M
Value
$16.15M

X4 Pharmaceuticals, Inc.
XFOR
Shares Held
1.96M
Value
$7.84M

Neurogene Inc.
NGNE
Shares Held
1.72M
Value
$35.37M

Jade Biosciences, Inc.
JBIO
Shares Held
969K
Value
$14.95M

Upstream Bio, Inc.
UPB
Shares Held
736K
Value
$19.98M

vTv Therapeutics Inc.
VTVT
Shares Held
298K
Value
$11.94M

Sutro Biopharma, Inc.
STRO
Shares Held
205K
Value
$2.37M

Nuvation Bio Inc.
NUVB-WT
Shares Held
124K
Value
$40.96K

Palvella Therapeutics, Inc.
PVLA
Shares Held
105K
Value
$10.97M

Abivax S.A.
ABVX
Shares Held
75K
Value
$10.17M

Contineum Therapeutics, Inc. Class A Common Stock
CTNM
Shares Held
72K
Value
$825.76K
